Previous 10 | Next 10 |
2024-07-12 12:39:02 ET Summary Pharmacy Benefit Managers are increasingly in the spotlight of regulators and the media, potentially leading to government intervention. Express Scripts, Cigna's PBM, is responsible for nearly 75% of the company's revenue, which raises the question o...
2024-07-12 12:35:09 ET More on Teva Pharmaceutical Teva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Teva Pharmaceutical: Buy This Bargain Before It's Gone Teva Pharmaceutical Industries Limited (TEVA) B...
2024-07-12 11:29:45 ET Summary Realty Income Corporation is setting itself up nicely for a great future by buying top-tier properties in times of economic hardship. Realty Income is a blue chip REIT, which pays a dividend each month, which is ideal for people looking to get some c...
2024-07-12 08:13:20 ET This week's dividend activity included increased payouts from Bank of New York Mellon ( BK ) and Ryder ( R ) as well as declarations from companies like Procter & Gamble ( NYSE: PG ) and Costco ( NASDAQ: COST ).... Read the full artic...
2024-07-11 10:55:34 ET Summary Regulatory scrutiny over CVS's PBM business may limit upside potential, with concerns about manufacturer-linked rebates and fees expected to come under focus. The stock's FCF yield is currently below average and is likely to remain that way, given th...
2024-07-10 14:14:20 ET More on Cigna, CVS Health, etc. CVS Health: A Better Investment Than Walgreens Boots Alliance UnitedHealth Group: The Perfect Portfolio Balancer CVS Health: Good Buy Vs. Goodbye Leading PBMs to face congressional hearing on July 23: Axi...
2024-07-10 08:50:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. U.S. equities rose in ...
2024-07-10 06:44:47 ET More on Cigna, CVS Health, etc. CVS Health: A Better Investment Than Walgreens Boots Alliance UnitedHealth Group: The Perfect Portfolio Balancer CVS Health: Good Buy Vs. Goodbye Pharma middlemen benefit at the expense of patients: FTC ...
2024-07-09 13:00:03 ET Summary CVS Health reported mediocre first quarter results, missed analyst's expectations and lowered guidance for fiscal 2024. However, CVS Health might actually profit from a struggling competitor Walgreens Boots Alliance and is certainly the better invest...
2024-07-09 10:51:57 ET More on Cigna, CVS Health, etc. UnitedHealth Group: The Perfect Portfolio Balancer CVS Health: Good Buy Vs. Goodbye Vltava Fund - CVS Health Corp.: Why We Sold CVS Medicare Advantage linked to fattest gross profits in health insurance: ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased securities of CVS Health Corporat...
CVS Health to hold second quarter 2024 earnings conference call PR Newswire WOONSOCKET, R.I. , July 8, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, August 7 th , 2024, at 8:00 a.m. ET ...
2024-07-03 08:15:00 ET Some beaten-down stocks have significant upside potential and, therefore, present attractive buying opportunities for investors. However, other companies that are failing to keep pace with the market and are likely to keep struggling for a long time aren't worth inves...